Matthew J. D'Onofrio's most recent trade in Evoke Pharma Inc was a trade of 1,000 Common Stock done at an average price of $2.8 . Disclosure was reported to the exchange on March 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Evoke Pharma Inc | Matthew J. D'Onofrio | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 2.80 per share. | 21 Mar 2025 | 1,000 | 9,820 (0%) | 0% | 2.8 | 2,797 | Common Stock |
| Evoke Pharma Inc | Matthew J. D'Onofrio | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 3.65 per share. | 28 Feb 2025 | 6,849 | 8,820 (0%) | 0% | 3.7 | 24,999 | Common Stock |
| Evoke Pharma Inc | Matthew J. D'Onofrio | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Evoke Pharma Inc | Matthew J. D'Onofrio | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2024 | 64,840 | 64,840 | - | - | Stock Option (Right to Buy) | |
| Evoke Pharma Inc | Matthew J. D'Onofrio | President & Chief Op. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Evoke Pharma Inc | Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Evoke Pharma Inc | Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Evoke Pharma Inc | Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Sale of securities on an exchange or to another person at price $ 2.91 per share. | 10 Dec 2020 | 40,357 | 283,997 (1%) | 0% | 2.9 | 117,439 | Common Stock |
| Evoke Pharma Inc | Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Sale of securities on an exchange or to another person at price $ 2.95 per share. | 10 Dec 2020 | 5,643 | 324,354 (1%) | 0% | 3.0 | 16,647 | Common Stock |
| Evoke Pharma Inc | Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Other type of transaction at price $ 1.05 per share. | 01 Sep 2020 | 20,238 | 283,997 (1%) | 0% | 1.1 | 21,250 | Common Stock |